ConductScience.org, home

Trial · NCT06748040

Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy

NCT06748040, Not applicable, Completed, Duke University; results first posted 2025-04-30

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy. Trials, record NCT06748040. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06748040

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy
NCT number
NCT06748040
Status
Completed
Phases
Not applicable
Enrollment
1,874 participants, actual
Lead sponsor
Duke University
Conditions
Chronic Kidney Disease, Hypertension
Interventions
Timing of return of results
First posted
2024-12-24
Last updated
2025-06-17
Results first posted
2025-04-30

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Systolic Blood Pressure From Baseline to 3 Months for APOL1 Negative ParticipantsBaseline to 3 month study visit

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange in Systolic Blood Pressure From Baseline to 3 Months for APOL1 Negative ParticipantsBaseline to 3 month study visitIntent To Treat (ITT) population for PGx substudy.mmHgMEAN

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change in Systolic Blood Pressure From Baseline to 3 Months for APOL1 Negative ParticipantsImmediate Return of Results-3.7Standard Deviation 19.0mmHg
Change in Systolic Blood Pressure From Baseline to 3 Months for APOL1 Negative ParticipantsDelayed Return of Results-3.1Standard Deviation 19.0mmHg

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDImmediate Return of Results953
Overall StudySTARTEDDelayed Return of Results921
Overall StudyCOMPLETEDImmediate Return of Results813
Overall StudyCOMPLETEDDelayed Return of Results780
Overall StudyNOT COMPLETEDImmediate Return of Results140
Overall StudyNOT COMPLETEDDelayed Return of Results141

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityImmediate Return of Results3953
Total, all-cause mortalityDelayed Return of Results4921
Total, other adverse eventsImmediate Return of Results00
Total, other adverse eventsDelayed Return of Results00
Total, serious adverse eventsImmediate Return of Results00
Total, serious adverse eventsDelayed Return of Results00

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
35660539BACKGROUND

Source PubMed

Grants4

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource
U01HG007269IGNITE EP2 - Admin SupplementCAVALLARI, LARISA HUMMA; JOHNSON, JULIE A.UNIVERSITY OF FLORIDANATIONAL HUMAN GENOME RESEARCH INSTITUTE2013 to 2024NIH RePORTER
U01HG010225The IGNITE II CC: Engagement, Coordination, Demonstration, and DisseminationWYATT, CHRISTINA M; CHAKRABORTY, HRISHIKESHDUKE UNIVERSITYNATIONAL HUMAN GENOME RESEARCH INSTITUTE2018 to 2024NIH RePORTER
U01HG010245Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.SKAAR, TODD C.; DEXTER, PAULINDIANA UNIVERSITY INDIANAPOLISNATIONAL HUMAN GENOME RESEARCH INSTITUTE2018 to 2024NIH RePORTER
U01HG010248GeNYC: Genomic Implementation Research in the Diverse Settings and Populations of New York CityHOROWITZ, CAROL RICAHN SCHOOL OF MEDICINE AT MOUNT SINAINATIONAL HUMAN GENOME RESEARCH INSTITUTE2018 to 2024NIH RePORTER

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Immediate Return of Results vs Delayed Return of Results: deaths from any cause

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06748040

GET https://conductscience.org/api/trials/v1/NCT06748040/registered